SLNCF — Silence Therapeutics Share News
0.000.00%
- $134.59m
- -$12.74m
- $43.26m
REG - Silence Therapeutics - Additional listing and Total Voting Rights
AnnouncementREG - Silence Therapeutics - Holdings in Company
AnnouncementREG - Silence Therapeutics - Grant of Options
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Silence Therapeutics Appoints Craig Tooman as CFO
AnnouncementREG - Silence Therapeutics - Board of Directors Appointment
AnnouncementREG - Silence Therapeutics - January Conference Schedule
AnnouncementREG - Silence Therapeutics - Holdings in Company
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Additional listing and Total Voting Rights
AnnouncementREG - Silence Therapeutics - Director/PDMR Shareholding
AnnouncementREG - Silence Therapeutics - Director/PDMR Shareholding
AnnouncementREG - Silence Therapeutics - Additional listing and Total Voting Rights
AnnouncementREG - Silence Therapeutics - Positive pre-clinical data presented
AnnouncementREG - Silence Therapeutics - Silence Therapeutics Appoints Dr. Marie Wikström
AnnouncementREG - Silence Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Silence Therapeutics - Price Monitoring Extension
AnnouncementREG - Silence Therapeutics - Director/PDMR Shareholding
AnnouncementREG - Silence Therapeutics - Additional listing and Total Voting Rights
Announcement